Form 4: Supernus Pharmaceuticals Executive Receives Stock Grant
Insider Transaction (Form 4)
Frank Mottola, SVP, Chief Tech. Ops. Officer of Supernus Pharmaceuticals, Inc., received 1,650 shares of common stock on July 29, 2026.
Summary
- Grant/award: acquired 1,650 Performance Share Unit on July 29, 2026; holds 1,650 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Frank Mottola — Officer (SVP, Chief Tech. Ops. Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-29 | Grant/award | Performance Share Unit | 1,650 | — | — | 1,650 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-29 | Grant/award (1,650 shares) |
Keywords
insider transaction, Form 4, SUPN, SUPERNUS PHARMACEUTICALS, INC., neutral, Frank Mottola
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.